Outcome in unresectable glioblastoma: MGMT promoter methylation makes the difference. [electronic resource]
Producer: 20170612Description: 350-358 p. digitalISSN:- 1432-1459
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents, Alkylating -- therapeutic use
- Biopsy
- Central Nervous System Neoplasms -- diagnosis
- Chemoradiotherapy
- DNA Methylation
- DNA Modification Methylases -- genetics
- DNA Repair Enzymes -- genetics
- Dacarbazine -- analogs & derivatives
- Drug Resistance, Neoplasm -- genetics
- Female
- Follow-Up Studies
- Glioblastoma -- diagnosis
- Humans
- Longitudinal Studies
- Male
- Middle Aged
- Prognosis
- Promoter Regions, Genetic
- Prospective Studies
- Salvage Therapy
- Temozolomide
- Tumor Suppressor Proteins -- genetics
- Young Adult
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.